Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate CancerByBenjamin P. SaylorOctober 22nd 2025
Supplemental Xtandi Does Not Improve Metastasis-Free Survival in High-Risk Prostate Cancer ByRyan ScottOctober 19th 2025
Truqap Extends Radiographic Progression-Free Survival in Some With Prostate CancerBySilas InmanOctober 19th 2025